Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1529 of 6351
-
New hope for toddlers with esophagus inflammation: dupilumab trial launches
Disease control Recruiting nowThis study is researching an experimental drug called dupilumab (called "study drug"). The study is focused on children with active eosinophilic esophagitis (EoE; an inflammatory disease of the esophagus) which impacts feeding and nourishment. The aim of the study is to see how …
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New combo pill aims to tame stubborn ulcerative colitis
Disease control Recruiting nowThe main purpose of the study is to evaluate the effectiveness and safety of LY4268989 when given with mirikizumab compared to mirikizumab alone in adult participants with moderately to severely active ulcerative colitis (UC). Study participation will last approximately 118 week…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a brain booster ease Parkinson's? new trial launches
Disease control Recruiting nowThe clinical manifestations of Parkinson's disease (PD), a chronic neurodegenerative condition, include resting tremor, hypokinesia, bradykinesia, stiffness and postural instability. These motor symptoms are caused by a selective loss and degeneration of dopaminergic neurons in t…
Phase 2/3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a common diabetes drug ease Parkinson's?
Disease control Recruiting nowThe clinical manifestations of Parkinson's disease (PD), a chronic neurodegenerative condition, include resting tremor, hypokinesia, bradykinesia, stiffness and postural instability. These motor symptoms are caused by a selective loss and degeneration of dopaminergic neurons in t…
Phase 2/3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New cholesterol pill may help those who can't tolerate statins
Disease control Not yet recruitingBempedoic acid is an oral, non-statin LDL-cholesterol (LDL-C) lowering agent that inhibits ATP citrate lyase (ACL), upstream of HMG-CoA reductase (the enzyme inhibited by statins). MDPI +1 In patients with hypercholesterolemia who are unable to tolerate statins, or have sub-op…
Phase 3 • Sponsor: Sohaib Ashraf • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can radiation make immunotherapy work better in kidney cancer?
Knowledge-focused Recruiting nowThe goal of this multicenter observational study is to elucidate the clinical and immunological characteristics of the abscopal effect in patients with metastatic renal cell carcinoma (mRCC) receiving immune checkpoint inhibitors (ICI) combined with image-guided ultra-hypofractio…
Sponsor: Zhe Chen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Wegovy's Real-World weight loss power tested in 500 korean patients
Disease control By invitation onlyThis study is to investigate the effectiveness and safety of Wegovy (semaglutide) in Korean patients living with obesity in routine clinical practice. The purpose of this study is to investigate the change in body weight and other clinical characteristics related to body weight i…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a simple injection replace major surgery for ovarian cancer staging?
Diagnosis Recruiting nowThis clinical trial investigates the sentinel lymph node (SLN) technique as a less invasive alternative to conventional lymphadenectomy in patients with early-stage ovarian cancer. The primary objective is to evaluate the effectiveness, safety, and diagnostic accuracy of the SLN …
Phase 3 • Sponsor: Instituto de Investigacion Sanitaria La Fe • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Umbilical cord stem cells could mend Worn-Out knees
Disease control Recruiting nowTesting the safety and efficacy of MSC from umbilical cord tissue (UC-MSC) for the treatment of cartilage damage in the knee joint
Phase 1/2 • Sponsor: BIONCaRT GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New genetic test may predict prostate cancer drug response before surgery
Knowledge-focused Recruiting nowThe PARIS-BIO study evaluates whether a novel genomic biomarker, the PCAI ImmunoScore, can predict the response to neoadjuvant treatment with Darolutamide in patients with high-risk localized or locally advanced prostate cancer. Patients will receive Darolutamide monotherapy for …
Phase 2 • Sponsor: Region Stockholm • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New flu pill shows promise for teens in Late-Stage trial
Symptom relief OngoingThis trial is conducted in China. This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of ZSP1273 in the treatment of Acute Uncomplicated influenza A in adolescents.
Phase 3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
A simple blood draw could spot bladder Cancer's return
Knowledge-focused Recruiting nowThis prospective observational study evaluates a blood-based circulating tumor DNA (ctDNA) test in patients with muscle-invasive bladder cancer or upper tract urothelial cancer. ctDNA consists of small fragments of tumor DNA that can sometimes be detected in the blood. In this s…
Sponsor: AZ Sint-Lucas Gent • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New hope for advanced cancer patients: first human trial of SIM0609 begins
Disease control Recruiting nowThis is an open-label,multicenter phase I study to evaluate the safety,Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0609 in Adult Participants with Locally Advanced/Metastatic Solid Tumors
Phase 1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New shot for eczema shows promise in early trial
Disease control Recruiting nowThis trial was designed to evaluate the efficacy and safety of SHR-1905 in patients with moderate-to-severe atopic dermatitis.
Phase 2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Heart mapping study could personalize AFib ablation and reduce repeat procedures
Knowledge-focused Recruiting nowAtrial fibrillation (AF) is the most common heart rhythm disorder, affecting millions worldwide and causing symptoms such as palpitations, fatigue and breathlessness. It also increases the risk of stroke and heart failure, so effective treatment is essential. A treatment for AF …
Sponsor: Barts & The London NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Dengue vaccine gets a makeover: new formula tested in phase 3 trial
Vaccine OngoingDengue fever is caused by an infection with the dengue virus. Vaccination with Dengue Tetravalent Vaccine (TDV) can help prevent dengue fever. The TDV in current formulation has been approved by health authorities in many countries around the world. The main aim of the study is t…
Phase 3 • Sponsor: Takeda • Aim: Vaccine
Last updated Jul 19, 2026 00:00 UTC
-
Can starting a new rescue inhaler in the ER keep asthma patients out of the hospital?
Disease control Recruiting nowThe study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could a simple supplement boost brain function in Parkinson's?
Disease control Recruiting nowThe goal of this clinical trial is to learn if taking a tributyrin supplement works to improve memory and thinking and walking and balance in adults with Parkinson disease Parkinson disease dementia. It will also learn about the safety of tributyrin supplementation. The main ques…
Phase 1/2 • Sponsor: Prabesh Kanel • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New shot could ease knee pain for millions with arthritis
Symptom relief Recruiting nowA Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.
Phase 3 • Sponsor: Saol Therapeutics Inc • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Zapping the brain while training the ear: a new tactic to hear one voice in a crowd
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if non-invasive brain stimulation (called transcranial stimulation) can enhance the benefits from auditory training in people who struggle to understand one talker when many people are talking at the same time. The main questions it aim…
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC